InsidersTradesSigma
Browse the full record of transactions filed by Bellemin Jean-Marc, Chief Financial Officer. Insider active across 1 companies, notably Iovance Biotherapeutics, INC.. Cumulatively, 1 reports have been logged. The latest transaction was filed on 14 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Jean-Marc Bellemin serves as Chief Financial Officer at IOVANCE BIOTHERAPEUTICS, INC. In this role, he oversees the company's financial management, including financial planning and regulatory compliance. Jean-Marc plays a key role in optimizing financial resources and in strategic decision-making to support the company's growth.